Otonomy competitorsClear all

Otonomy's top competitors include BeyondSpring, Inovio Pharmaceuticals, MyoKardia and Athersys.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
BeyondSpring
BeyondSpring
BeyondSpring is a clinical-stage biopharmaceutical company.
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Athersys
Athersys
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
Founding Date
Founding Date
2008
Founding Date
2010
Founding Date
1979
Founding Date
2012
Founding Date
1995
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
New York, US HQ
Locations
Plymouth Meeting, US HQ
San Diego, US
San Diego, US
Locations
South San Francisco, US HQ
Locations
Cleveland, US HQ
Canton, US
Employees
Employees
498% decrease
Employees
5237% increase
Employees
2811% increase
Employees
1024% increase
Employees
7514% increase
Valuation ($)
Valuation ($)
73.6 m
Valuation ($)
N/A
Valuation ($)
244.1 m
Valuation ($)
2.2 b
Valuation ($)
241.1 m
Twitter followers
Twitter followers
233
Twitter followers
51
Twitter followers
1.9 k
Twitter followers
673
Twitter followers
1.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
8
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5.3
Average likes per tweet (last 30 days)
8.3
Average likes per tweet (last 30 days)
20
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
318925
Alexa Website Rank
N/A
Alexa Website Rank
402192
Alexa Website Rank
378335
Alexa Website Rank
609659

Financial

Revenue (est.)
Revenue (est.)
$745k (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
$30.5m (FY, 2018)
Revenue (est.)
$33.6m (FY, 2018)
Revenue (est.)
$24.3m (FY, 2018)
Net income
Net income
($50.4m) (FY, 2018)
Net income
($57.5m) (FY, 2018)
Net income
($97m) (FY, 2018)
Net income
($67.7m) (FY, 2018)
Net income
($24.3m) (FY, 2018)

Operating

Patent Applications
Patent Applications
N/A
Patent Applications
56 (FY, 2018)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
170 (FY, 2016)
Patents (US)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
4 (FY, 2017)
Patents (US)
21 (FY, 2016)
Patents Issued
Patents Issued
88 (FY, 2016)
Patents Issued
20 (FY, 2018)
Patents Issued
620 (FY, 2016)
Patents Issued
N/A
Patents Issued
200 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
1 (FY, 2016)
Phase I Trials Products
2 (FY, 2018)
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2017)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
2 (FY, 2016)
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
1 (FY, 2017)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
3 (FY, 2018)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Preclinical Phase Products
Preclinical Phase Products
1 (FY, 2016)
Preclinical Phase Products
5 (FY, 2018)
Preclinical Phase Products
N/A
Preclinical Phase Products
3 (FY, 2017)
Preclinical Phase Products
N/A

Funding

Total funding raised
Total funding raised
$ 153.4m
Total funding raised
$ 3.8m
Total funding raised
$ 63.3m
Total funding raised
$ 98m
Total funding raised
$ 9m
For sources of this data, please see the company profile

View company profiles

BeyondSpring
HQ
New York, US
Employees
52↑ 37% increase

BeyondSpring is a clinical-stage biopharmaceutical company.

View company
Inovio Pharmaceuticals
HQ
Plymouth Meeting, US
Employees
281↑ 1% increase

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.

View company
MyoKardia
HQ
South San Francisco, US
Employees
102↑ 4% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Athersys
HQ
Cleveland, US
Employees
75↑ 14% increase

Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

View company